姜黄素类似物合成与体外抗肿瘤活性研究

以芳香醛、4-哌啶酮为原料,Claisen-Schimidt缩合制备3,5-(E)-二亚苄基哌啶-4-酮类化合物.采用MTT法测试目标化合物对人类慢性粒细胞白血病急变细胞K562,人结肠癌细胞SW1 116增殖的抑制活性.化合物1-19的结构经核磁和质谱确证,化合物7、10、11对SW1 116的抑制活性比EF-24强...     

几种姜黄素类1,4-戊二烯-3-酮衍生物的合成及结构表征

以芳香醛和酮为原料,合成了3类姜黄素类1,5-二芳基-1,4-戊二烯-3-酮衍生物:1,5-二噻吩基-1,4-戊二烯-3-酮(Ⅰ)、1,5-二苯基-1,4-戊二烯-3-酮类(Ⅱ)和1,5-二呋喃基-1,4-戊二烯-3-酮(Ⅲ);利用元素分析、红外光谱、核磁共振谱(1 H NMR及13 C NMR)分析了产物的组成和结构,初步探讨了其反应条件和反应机理.结果表明,以无水乙醇为溶剂、8%的NaOH溶液为催化剂,反应温度为30⁵0℃时,反应产率较高.     

新型姜黄素类似物的微波合成及其抗氧化活性

采用微波法,取代苯甲醛分别与环戊酮和环己酮经克莱森-斯密特缩合反应制得中间体2,6-双苯亚甲基环己酮(2a~2e)和2,5-双苯亚甲基环戊酮(5a);2a~2e或5a分别与硫脲或尿素经Biginelli反应合成了8个新型的姜黄素类似物(3a~3e,4a,4c和6a),其结构经1H NMR,13C NMR,IR和MS表征。利用DPPH法比较3~6与姜黄素的抗氧化能力。实验结果表明:3~6的抗氧化能力均比姜黄素母核结构高;3比4和6的自由基清除能力强;随用药量增大,抗氧化能力呈现先增强后下降的趋势,并在0.09 mg·mL-1~0.12 mg·mL-1自由基清除率达最大。     

新型含氟姜黄素类似物的合成、晶体结构及抗肿瘤活性

采用活性基团拼接法将含氟苯甲醛与酮反应, 合成了5个含氟单羰基姜黄素类似物, 结构经IR, ¹H NMR及ESI-MS确认. 对所合成的化合物进行了抗肿瘤活性测试(MTT法), 结果表明, 部分化合物对肿瘤细胞有较强的选择性抑制活性, 其中2,6-二(4-氟亚苯基)环己酮(3a)和2,6-二(2-氟亚苯基)环己酮(3b)的抗肿瘤谱广, 活性较好, 就此对化合物3b作了单晶培养, 并就晶体结构进行了X衍射分析. 结构表明化合物3b属三斜晶系, 空间群 P-1. 晶胞参数 a＝0.9222(2) nm, b＝0.9732(2) nm, c＝1.0127(2) nm, α＝88.920(4)°, β＝75.672(3)°, γ＝62.404(3)°, V＝0.7755(3) nm³, Z＝2, D_c＝1.329 Mg•m^－3, μ＝0.097 mm^－1, F(000)＝324, 最终偏离因子R＝0.0590, wR＝0.1841.     

螺杂环单羰基姜黄素类似物的合成、晶体结构与抗肿瘤活性研究

为了发现新型姜黄素类抗肿瘤先导化合物,通过1,3-偶极环加成反应合成了14个螺杂环单羰基姜黄素类似物.该反应利用无需加催化剂的"一锅煮"方法合成,具有环境友好的优点.所有化合物结构经ESI-MS、ESI-HRMS和1H NMR确认,通过X衍射确证B6的晶体结构为单斜晶系,该类化合物的合成具有良好的区域选择性和立体选择性.通过噻唑兰(MTT)法测定所有化合物对人胃癌细胞SGC-7901、神经胶质瘤细胞U251、人大细胞肺癌细胞株NCI-H460的增殖抑制活性,部分化合物表现出了较好的活性.其中B1、B6、B7和B11对三种肿瘤细胞均表现出较好的抗肿瘤活性,而对正常人肝细胞HL-7702显示了相对较低的细胞毒性.化合物B1和B7均能明显诱导凋亡相关蛋白含半胱氨酸的天冬氨酸蛋白水解酶3(caspase3)和多聚ADP-核糖聚合酶(PARP)的活化,诱导肿瘤细胞发生凋亡.所合成的螺杂环单羰基姜黄素类似物为新型的抗肿瘤化合物,该类化合物可能在靶向抗肿瘤药物研发方面具有较好的研究前景.     

姜黄素类似物的合成及其清除自由基的研究

姜黄素(见图1)为中药姜黄的主要成分,是一种黄色色素。研究报道姜黄素具有抗氧化、抗炎、抗病毒、抗癌等生物活性[1-4]。本文通过芳香醛和环己酮催化缩合反应合成了一系列姜黄素类似物(见图2),研究了它们抗自由基的活性。图1姜黄素的化学结构F ig.1 Chem ical structure of cur     

含氮含硫姜黄素类似物的微波合成及抗氧化活性研究

利用微波辐射合成含氮含硫的姜黄素类似物,比较了化合物的抗氧化能力。以苯甲醛与环戊酮或环己酮为原料,经克莱森-斯密特缩合反应,采用微波法合成中间化合物2,6-双苯亚甲基环己酮或2,5-双苯亚甲基环戊酮,中间体与尿素或硫脲经Biginelli反应合成目标化合物。利用DPPH法比较各化合物与姜黄素的抗氧化能力。合成了2个未见文献报道的新化合物(2b,2c),结构经IR、1H NMR、13C NMR和MS表征确证;增加含氮、含硫基团的衍生物,其抗氧化能力比姜黄素母核结构高。采用微波法合成含氮含硫的姜黄素类似物可显著提高产率,产率达83%,经24 h含氮、含硫化合物b的抗氧化能力与姜黄素相当,远比姜黄素母核强。     

瑞香酮类似物的合成与生物活性研究

以瑞香狼毒(Stellera chamaejasme L.)中分离得到的天然产物(E)-1,5-二苯基-2-烯-1-戊酮(I)为先导,用不同的含氮杂环取代1-苯基,设计合成了8个未见报道的化合物,其结构均经过1HNMR,IR和元素分析确证.初步生物活性测试表明,目标化合物在600μg/mL浓度下表现出一定的杀蚜活性,其中化合物6a对棉蚜的校正死亡率为92.9%,活性优于先导I.     

含哌啶酮结构单元的姜黄素类似物的合成及其诱导癌细胞凋亡活性

以邻甲氧基苯甲醛为原料,经羟醛缩合反应合成了6个单羰基姜黄素类似物（1a~1f）,其结构经¹H NMR和¹³C NMR确证。采用MTT法研究了1a~1f对人肺癌细胞A549和NCI-H460的抑制活性。结果表明：大部分化合物的活性显著优于天然产物姜黄素。其中3,5-二(2-甲氧基苯亚甲基)-4-哌啶酮（1d）可促进细胞活性氧的产生,对A549有诱导凋亡效果。     

超声技术合成1,5-二-(4-羟基苯基)-1,4-戊二烯-3-酮

利用对羟基苯甲醛和丙酮为原料,以氯化氢气体为催化剂,超声波辐射下成功合成了1,5-二-(4-羟基苯基)-1,4-戊二烯3-酮(HPD).与传统方法相比,该方法具有反应时间短,操作简便及产率高等优点,并讨论了影响产率的因素.     

Synthesis and study of the opioid activities of analogues of β-casomorphin-5

V. I. Lenin Tadzhik State University, Dushanbe. M. V. Lomonosov Moscow State University. Translated from Khimiya Prirodnykh Soedinenii, No. 4, pp. 565–567, July–August, 1990.     

Synthesis and photo DNA-damaging activities of fluoroquinolone analogues

Fluoroquinolone (FLQ) analogues were synthesized and their DNA photocleaving abilities were assayed. The photo-bioactivities of the fluoroquinolones were dependent on the carbonyl moieties attached to quinolone ring.     

Synthesis and antiviral activities of carbocyclic oxetanocin analogues

9-Cyclobutyladenine (4a), cis- and trans-9-[3- (hydroxymethyl)cyclobutyl]adenine (4b) and 9-[3,3-bis(hydroxymethyl)cyclobutyl]adenine(4d) were prepared from the corresponding cyclobutylamine derivatives (1a, 1b and 1d). Guanine congeners (9a, cis- and trans-9b and 9d) and carbocyclic oxetanocin G (1',2'-trans-9f) were also prepared. Carbocyclic oxetanocin A(1',2'-trans-4f), the preparation of which we have already published, and G were found to be active against herpes simplex virus (type 1 and 2) in vitro, while cis-4b and cis-9b showed an in vitro antiretroviral activity against human immunodeficiency virus (type 1).     

Synthesis of febrifuginol analogues and evaluation of their biological activities

A new series of febrifuginol analogues was prepared from l-glutamic acid. An antimalarial activity evaluation against chloroquine-sensitive (T96) and chloroquine-resistant (K1) Plasmodium falciparum indicated that all the tested compounds had very strong inhibitory activity. Compounds 4 and 17b′ were inactive against KB, MCF7, HepG2 and LU1 cell lines even at a concentration of 100 μM, while they exhibited significant inhibition towards P. falciparum. Comparison of the antimalarial activity and the cytotoxic properties revealed that the 2′S isomers were more active than the corresponding 2′R isomers for this series of febrifuginol analogues, indicating that the C-2′ position is critical for the biological activity of this class of compounds.     

Synthesis and biological activities of conformationally restricted cyclopentenyl-glutamate analogues.

An efficient method for preparing conformationally restricted cyclopentenyl-glutamate analogues in a regioselective and diastereoselective manner has been developed using a formal [3 + 2] cycloaddition reaction of dehydroamino acids. Methods for preparing optically active versions of these compounds have also been devised. Of these compounds, (S)-2 is an agonist at the mGlu5 (EC(50) 18 microM) and mGlu2 (EC(50) 45 microM) receptors.     

Synthesis and antagonistic activities of enantiomers of cyclic platelet-activating factor analogues

Enantiomers of platelet-activating factor (PAF) antagonists, 3-(6-[O-(trans-3-heptadecylcarbamoyloxytetrahydropyran-2-yl)methyl ] phosphonoxy)hexylthiazolium (inner salt) (3), 3-[5-(trans-3-heptadecylcarbamoyloxytetrahydropyran-2-yl) methoxycarbonylamino]pentylthiazolium bromide (4) and 3-(5-[O-(cis-3-heptadecylcarbamoylthiotetrahydropyran-2-yl) methyl]phosphonoxy)pentylthiazolium (inner salt) (5), were synthesized, starting from (2R,2R)- and (2S,2S)-tartaric acid. Antagonistic activities of these compounds against C16-PAF were measured in vitro (rabbit platelet aggregation, IC50) and in vivo (hypotension in rats, ID50). In these three enantiomeric pairs, the (3S)-(tetrahydropyran numbering) enantiomers were one order more potent than the (3R)-isomers: (2R,3S)-3a (R-74,654), IC50 0.59 microM and ID50 0.054 mg/kg, i.v.; (2S,3R)-3b, IC50 4.7 microM and ID50 0.30 mg/kg, i.v.; (2R,3S)-4a, IC50 0.20 microM and ID50 0.032 mg/kg, i.v.; (2S,3R)-4b, IC50 2.2 microM and IC40 0.21 mg/kg, i.v.; (2R,3R)-5a, IC50 1.1 microM and ID50 0.92 mg/kg, i.v.; (2S,3S)-5b (R-74,717), IC50 0.27 microM and ID50 0.064 mg/kg, i.v.     

Synthesis of bisubstrate analogues targeting alpha-1,3-fucosyltransferase and their activities

We designed two bisubstrate analogues targeting alpha-1,3-fucosyltransferases, based on the three dimensional structure of Lewis X, which is the product of a alpha-1,3-fucosyltransferase reaction. We selected guanosine-5'-diphospho-L-galactose as a donor mimic and 2-hydroxyethyl beta-D-galactoside as an acceptor mimic, and tethered these two mimics with a methylene or ethylene linker. For the synthesis, the 6-position of L-galactose and the 6-position of D-galactose were first tethered via a methylene or ethylene linker. The L-galactose moiety was then converted to a GDP derivative. Both bisubstrate analogues were moderate inhibitors against alpha-1,3-fucosyltransferase V and VI. The fact that they were substrates of alpha-1,3-fucosyltransferase VI suggested that these compounds bound to the donor binding site, but not to the acceptor binding site.     

Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities

[reaction: see text] Sialyltransferases (STs) are involved in the biosynthesis of glycoconjugates with important biological activities. Most STs utilize cytidine-5'-monophospho-N-acetylneuraminic acid (CMP-Neu5Ac) as a common donor substrate. A bisubstrate analogue containing the donor substrate (CMP-Neu5Ac mimic) and the acceptor substrate (galactose) was synthesized. Four donor analogues having the partial structure of the bisubstrate analogue were also synthesized to support study of the structure-activity relationship. Each analogue contains an ethylene group in place of the exocyclic anomeric oxygen of CMP-Neu5Ac. The bisubstrate analogue exhibited only weak inhibitory activity to rat recombinant alpha-2,3- and alpha-2,6-ST (IC(50) = 1.3, 2.4 mM). Conversion of the C-1 carboxylate of the Neu5Ac moiety to carboxyamide, hydroxymethyl, or methylene phosphate each resulted in a reduction in inhibitory activity. Among the synthesized analogues, cytidin-5'-yl sialylethylphosphonate (4) was the most potent inhibitor against rat recombinant alpha-2,3- and alpha-2,6-ST (IC(50) = 0.047, 0.34 mM).     

Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues

Invariant natural killer T (iNKT) cells are innate T lymphocytes that express T cell receptors binding to exogenous and endogenous glycosphingolpid antigens presented by a nonpolymorphic, non-MHC antigen presenting molecule, CD1d. The endogenous glycosphingolipid metabolite, isoglobotrihexosylceramide (iGb3), is the first known natural ligand for both human and mouse iNKT cells, whose activity has been confirmed in a variety of iNKT cell clones generated by different investigators, representing the majority of the iNKT cell population. The signaling pathway mediated by T cell receptor is largely influenced by the structural variation of glycosphingolpid antigens, leading to multiple and varied biological functions of iNKT cells. In order to investigate the structural requirements behind iGb3 triggered iNKT cell activation, the structure-activity relationship (SAR) of iGb3 needs to be characterized. In this study, iGb3 analogues containing 2' ', 3' ', 4' ' and 6' ' deoxy terminal galactose were synthesized for probing the SAR between iGb3 and TCR. The biological assays on the synthetic iGb3 analogues were performed with use of the murine iNKT cell hybridoma DN32.D3. The results showed that the 2' ' and 3' ' hydroxyl groups of terminal galactose play more important roles for the recognition of iGb3 by TCR; while 4' ' and 6' ' hydroxyl groups were not as crucial for this recognition. These studies might help to understand the general structural requirements for natural endogenous ligands recognized by iNKT cells.     

Synthesis and aldose reductase inhibitory activities of benzyl 2-oxazolecarbamate analogues.

Various analogues of benzyl 5-phenyl-2-oxazolecarbamate (1a) were synthesized, and the structure-activity relationship of these analogues as aldose reductase inhibitor was studied. The carbamate group was necessary for the inhibitory activity. The introduction of an alkyl group at the C-4 position of 1a enhanced the inhibitory activity, however, the N-carboxymethyl group on the carbamate moiety counteracted to a hydrophobic interaction between the alkyl group at the C-4 position and the enzyme molecule.